Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New
treatment options are becoming available, and there is a need to characterize the …

Abstract Background and Aim: Decisions on public health issues are dependent on reliable
epidemiological data. A comprehensive review of the literature was used to gather country …

Hepatitis C virus (HCV) affects 130-210 million people worldwide and is one of the major
risk factors for hepatocellular carcinoma. Globally, at least one third of hepatocellular …

Background Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …

Abstract Background Hepatitis C virus (HCV) is a leading cause of chronic liver disease, end-
stage cirrhosis, and liver cancer, but little is known about the burden of disease caused by …

Three percent of the world's population is chronically infected with the hepatitis C virus
(HCV) and at risk of developing liver cancer. Effective cellular immune responses are …

Spain has a medium endemicity of hepatitic C infection among central Europe countries and
Italy. Prevalence of anti-HCV varies among regions and it ranges from 1.6 to 2.6%, which …

BACKGROUND & AIMS: The dynamics of hepatitis C virus (HCV) infection, as well as
screening practices and access to therapy, vary among European countries. It is important to …

OBJECTIVES: Limited information suggests the existence of a high prevalence of hepatitis B
(HBV) and C virus (HCV) infection in inflammatory bowel disease (IBD). This knowledge is …

Screening of hepatitis C virus infection in adult general po... : European Journal of
Gastroenterology & Hepatology Screening of hepatitis C virus infection in adult general …